drugset / Press release

The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells

2023-09-06 · ImaginAb, Inc. · original imaginab.com ↗

back The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells presented at WMIC 2023

The release as fetched from its publisher. imaginab.com ↗